Research & Development: Page 103
-
PharmaVoice Team/PharmaVoice
On the Calendar
June 6-7 Pharmaceutical Marketers KnowledgeShare Forum 2005: Building Brand Differentiation in the Current Regulatory Climate Airport Marriott, Philadelphia This is a PharmaVOICE event, subscribers are eligible for a 15% discount; register using code PVMKS05. For more information, contact Micah L...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-Media June 2005 PharmaVOICE SAS Upgrades Scientific Discovery Solutions In response to the need for modernization in the drug-development process, SAS Institute Inc. has made significant upgrades and additions to its Scientific ...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies PMI Appoints Task Force to Oversee CME Compliance Pri-Med Institute (PMI) has named a task force of medical and educational experts to ensure that all of its continuing medical education (CME) programs meet and exceed the new Standards of C...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions What’s on your mind What have you heard lately? In the September issue of PharmaVOICE, we asked readers to relate the most surprising statistics or strange facts that they have come across. PharmaVOICE learned that every human spent about half an hour as a single cell and that 70% of con...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter from the Editor By Taren Grom Editor Driving business forward According to the U.S. Small Business Administration, more than 50% of small businesses fail in the first year and 95% fail within the first five years. Some entrepreneurs describe their decision to set up their own business as a...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On The Cover Flying high on a vision Even as pharmaceutical companies merge to form giant conglomerates, business leaders are choosing to step out on their own and are taking some calculated risks. They embrace the challenges that come with being an entrepreneur and strive to make a difference in...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
November 18-20, 2003, Westin Copley Place — Boston LogiPharma 2003 This is an opportunity for attendees to hear how competitors and peers are maximizing every facet of their supply-chain strategy. The event provides the opportunity to hear more than 25 confirmed case studies delivered by senior-l...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
November 2003E-media MDS Pharma Express is intuitive, user-friendly, and designed to operate with minimal computer requirements and the highest level of Internet security –providing easy access to current study status information in real time, anytime. MDS Electronic Data-Delivery System Allows f...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating a Guidance System for Life-Science Brands
Creating a Guidance System for Life-Science Brands While meaningful biomedical research depends on proteomics, genetics, and genomics tools, their ultimate application also will depend on successful commercialization and marketing tools. Mark Stinson President ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Recruitment: To Centralize or Decentralize? This is the Question.
Recruitment: To Centralize or Decentralize? This is the Question. Liz Moench President and CEO Patient and Investigator Recruitment In many people’s minds, centralized recruitment often symbolizes big money and big studies. But in actuality, nothing could...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategic Phase II Planning -- More Important Than Ever for the Biotech Industry
Strategic Phase II Planning — More Important Than Ever for the Biotech Industry Lukas Makris, Ph.D. CEO Phase II programs should not only be judged on how well the objectives were met, but on how well they might predict the Phase III outcome. The biotechnology industr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Robust Future for Phase IV Trials
A Robust Future for Phase IV Trials May 2005 VIEW on Biotechnology Clinical Trials Dimensional HealthCare Inc., Cedar Knolls, N.J., designs, implements, and provides community-based research to the pharmaceutical and medical-device industries, focusing on the design and implementation of la...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of contents Letter from the Editor The Forum Biotech: The Perfect Storm — A relatively more favorable funding environment, cutting-edge technologies, and a strong position at the partnership table have many of today’s biotechnology companies in a position for success. Company Listing by Top...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Society of Hospital Medicine Launches New Medical Journal The Society of Hospital Medicine plans to launch a new peer-reviewed medical journal, The Journal of Hospital Medicine, in 2006. The journal will promote the science and practice of hospital medicine and the enhancement of in-patient care....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Infotrieve Introduces New Search and Discovery Tool The LSRC employs a radically different approach to discovery, evolving the traditional use of content from a “find-and-review” approach to a unique “search-discover-and-create” approach capable of delivering dramatic improvements in research pro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Nano-Enabled Drug Discovery Market to Reach $1.3 Billion by 2009 Nano-enabled drug-discovery solutions will generate revenue of $1.3 billion in 2009 and increase to $2.5 billion in 2012, according to a new report from NanoMarkets LC. The report, The Impact of Nanotechnology in Drug Discovery: Glo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
May 16-17 Global Clinical Trials Hyatt Regency Jersey City, Jersey City, N.J. For more information, contact Caria Badenhorst, Marcus Evans, at 246-417-5321, e-mail [email protected], or visit marcusevans.com. May 16-17 5th Annual Sample Accountability Hyatt Regency Princeton, Princeton, N....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Culture of compliance: Cutting through the confusion To be compliant with the many regulations and guidances that apply to the marketing of prescription products, companies need to create a culture of compliance that fosters and promotes an ethical atmosphere and compliant behavior. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dr. Leo H. Sternbach -- The Inventor's Inventor
Eminent scientist Leo H. Sternbach, Ph.D., is being inducted into the National Inventors Hall of Fame nearly 42 years after his landmark invention Valium was approved by the FDA. PharmaVOICE is taking this opportunity to honor Dr. Sternbach, 97, for his extraordinary achievements. We would like t...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Shifting the Compliance Paradigm
VIEW on regulatory compliance Michael Kuehne is President of ACSYS Inc., Hillsborough, N.J., which specializes in developing quality and compliance solutions that combine R&D and manufacturing capabilities to deliver sustained improvement in R&D, Quality, Operations, Clinical, and Regulat...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Diabetes: Novel Pipeline Compounds Offer New Hope
Tremendous progress has been made in the treatment of diabetes over the last decade. Still, many people with diabetes have poor glycemic control, and there is a need for more convenient therapies. As the prevalence of diabetes, especially type 2 diabetes, continues to increase, products in develo...
By Lisa Dress • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
On the Cover The Business of R&D Metrics Unlock Innovation with Marh Ahn Venture Capital Environment March 2005 www.pharmavoice.com Volume 5 Number 3 The Forum for the Industry Executive PharmaVOICE Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
February 15-17 WCBF Six Sigma in Chemicals & Pharmaceuticals Hyatt Regency Dallas, Dallas For more information, contact Louise Gosling, WCBF Six Sigma Solutions, at 44-14-83 76-0883, e-mail [email protected], or visit wcbf.com. February 15-18 18th Annual DIA Electronic Document Manageme...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Drug Development
Drug Development Strong Clinical-Trial Management Systems Market Offers Opportunities for suppliers, Clinical Sponsors, and CROs Alike The U.S. clinical-trial management systems (CTMS) market is poised for steady growth through 2008, achieving a five-year compound annual growth rate (CAGR) of abo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Financing
Kolodny-Hirsch. As a long-time participant in this industry, it is certainly encouraging to finally see that more biotech companies are on the verge of profitability. Nonetheless, there are still hundreds of private and publicly traded biotech firms that are in the red and struggling to survive. ...
By PharmaVoice Team • Jan. 2, 2008
Previous
